BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, Arthur MJ, Iredale JP, Mann DA. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology. 2001;121:685-698. [PMID: 11522753 DOI: 10.1053/gast.2001.27188] [Cited by in Crossref: 275] [Cited by in F6Publishing: 253] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Habens F, Srinivasan N, Oakley F, Mann DA, Ganesan A, Packham G. Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity. Apoptosis 2005;10:481-91. [PMID: 15909110 DOI: 10.1007/s10495-005-1877-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
2 Douglass A, Wallace K, Parr R, Park J, Durward E, Broadbent I, Barelle C, Porter AJ, Wright MC. Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury. Journal of Hepatology 2008;49:88-98. [DOI: 10.1016/j.jhep.2008.01.032] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
3 Fairhall EA, Charles MA, Wallace K, Schwab CJ, Harrison CJ, Richter M, Hoffmann SA, Charlton KA, Zeilinger K, Wright MC. The B-13 hepatocyte progenitor cell resists pluripotency induction and differentiation to non-hepatocyte cells. Toxicol Res 2013;2:308. [DOI: 10.1039/c3tx50030f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Lim MP, Devi LA, Rozenfeld R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis 2011;2:e170. [PMID: 21654828 DOI: 10.1038/cddis.2011.52] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
5 Chakraborty JB, Mann DA. NF-kappaB signalling: embracing complexity to achieve translation. J Hepatol. 2010;52:285-291. [PMID: 20022129 DOI: 10.1016/j.jhep.2009.10.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
6 Schulze-Bergkamen H, Schuchmann M, Fleischer B, Galle PR. The role of apoptosis versus oncotic necrosis in liver injury: facts or faith? J Hepatol 2006;44:984-93. [PMID: 16554101 DOI: 10.1016/j.jhep.2006.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
7 Weiskirchen R. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Front Pharmacol. 2015;6:303. [PMID: 26779021 DOI: 10.3389/fphar.2015.00303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
8 Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 2006;169:861-76. [PMID: 16936262 DOI: 10.2353/ajpath.2006.050767] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 7.7] [Reference Citation Analysis]
9 Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. J Biomed Sci. 2006;13:403-418. [PMID: 16604421 DOI: 10.1007/s11373-006-9079-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
10 Mòdol T, Natal C, Pérez de Obanos MP, Domingo de Miguel E, Iraburu MJ, López-zabalza MJ. Apoptosis of hepatic stellate cells mediated by specific protein nitration. Biochemical Pharmacology 2011;81:451-8. [DOI: 10.1016/j.bcp.2010.10.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
11 Zhang J, Gu C, Song Q, Zhu M, Xu Y, Xiao M, Zheng W. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma. Cell Biosci 2020;10:127. [PMID: 33292459 DOI: 10.1186/s13578-020-00488-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
12 Cheng K, Mahato RI. Gene modulation for treating liver fibrosis. Crit Rev Ther Drug Carrier Syst. 2007;24:93-146. [PMID: 17725523 DOI: 10.1615/critrevtherdrugcarriersyst.v24.i2.10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
13 Murphy F, Arthur M, Iredale J. Developing strategies for liver fibrosis treatment. Expert Opin Investig Drugs 2002;11:1575-85. [PMID: 12437504 DOI: 10.1517/13543784.11.11.1575] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
14 Xu P, Zhang Y, Liu Y, Yuan Q, Song L, Liu M, Liu Z, Yang Y, Li J, Li D, Ren G. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways. Toxicol Appl Pharmacol 2016;290:43-53. [PMID: 26592322 DOI: 10.1016/j.taap.2015.11.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
15 Davaille J, Li L, Mallat A, Lotersztajn S. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem. 2002;277:37323-37330. [PMID: 12138095 DOI: 10.1074/jbc.m202798200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
16 Thirunavukkarasu C, Watkins SC, Gandhi CR. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology. 2006;44:389-398. [PMID: 16871588 DOI: 10.1002/hep.21254] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
17 Tang X, Yang J, Li J. Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis. Life Sciences 2009;84:552-7. [DOI: 10.1016/j.lfs.2009.01.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
18 Wallace K, Marek CJ, Hoppler S, Wright MC. Glucocorticoid-dependent transdifferentiation of pancreatic progenitor cells into hepatocytes is dependent on transient suppression of WNT signalling. Journal of Cell Science 2010;123:2103-10. [DOI: 10.1242/jcs.070722] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
19 Mottaghitalab F, Rastegari A, Farokhi M, Dinarvand R, Hosseinkhani H, Ou KL, Pack DW, Mao C, Dinarvand M, Fatahi Y, Atyabi F. Prospects of siRNA applications in regenerative medicine. Int J Pharm 2017;524:312-29. [PMID: 28385649 DOI: 10.1016/j.ijpharm.2017.03.092] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
20 Li JT, Liao ZX, Ping J, Xu D, Wang H. Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol. 2008;43:419-428. [PMID: 18600385 DOI: 10.1007/s00535-008-2180-y] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 7.4] [Reference Citation Analysis]
21 Fallowfield JA, Kendall TJ, Iredale JP. Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis. 2006;10:481-497, viii. [PMID: 17162224 DOI: 10.1016/j.cld.2006.08.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
22 Madankumar P, Naveenkumar P, Devaraj H, Niranjalidevaraj S. Morin, a dietary flavonoid, exhibits anti-fibrotic effect and induces apoptosis of activated hepatic stellate cells by suppressing canonical NF-κB signaling. Biochimie 2015;110:107-18. [DOI: 10.1016/j.biochi.2015.01.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
23 Iredale JP, Pellicoro A. "It is a good morning exercise for a research scientist to discard a pet hypothesis every day before breakfast: it keeps him young" (Konrad Lorenz, 1903-1989). Gastroenterology 2011;140:1395-8. [PMID: 21443887 DOI: 10.1053/j.gastro.2011.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC, Pradere JP, Friedman RA, Schwabe RF. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012;143:1073-83.e22. [PMID: 22750464 DOI: 10.1053/j.gastro.2012.06.036] [Cited by in Crossref: 290] [Cited by in F6Publishing: 268] [Article Influence: 32.2] [Reference Citation Analysis]
25 Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927-939. [PMID: 16151628 DOI: 10.1007/s10495-005-1055-4] [Cited by in Crossref: 294] [Cited by in F6Publishing: 264] [Article Influence: 19.6] [Reference Citation Analysis]
26 Niu X, Fu N, Du J, Wang R, Wang Y, Zhao S, Du H, Wang B, Zhang Y, Sun D, Nan Y. miR-1273g-3p modulates activation and apoptosis of hepatic stellate cells by directly targeting PTEN in HCV-related liver fibrosis. FEBS Lett. 2016;590:2709-2724. [PMID: 27423040 DOI: 10.1002/1873-3468.12309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
27 Marek CJ, Wallace K, Durward E, Koruth M, Leel V, Leiper LJ, Wright MC. Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics. Comp Hepatol 2009;8:1. [PMID: 19432992 DOI: 10.1186/1476-5926-8-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
29 Park E, Zhao Y, Kim Y, Sohn DH. Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. European Journal of Pharmacology 2007;559:115-23. [DOI: 10.1016/j.ejphar.2007.01.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
30 Cheng CF, Pan TM. Ankaflavin and Monascin Induce Apoptosis in Activated Hepatic Stellate Cells through Suppression of the Akt/NF-κB/p38 Signaling Pathway. J Agric Food Chem 2016;64:9326-34. [PMID: 27960292 DOI: 10.1021/acs.jafc.6b03700] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
31 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 87-109. [DOI: 10.1016/b978-1-4160-3258-8.50011-5] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
32 Zheng J, Ma LT, Ren QY, Li L, Zhang Y, Shi HJ, Liu Y, Li CH, Dou YQ, Li SD, Zhang H, Yang MH. The influence of astragalus polysaccharide and β-elemene on LX-2 cell growth, apoptosis and activation. BMC Gastroenterol 2014;14:224. [PMID: 25551689 DOI: 10.1186/s12876-014-0224-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
33 Wang R, Yu XY, Guo ZY, Wang YJ, Wu Y, Yuan YF. Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling. J Ethnopharmacol 2012;144:592-8. [PMID: 23041223 DOI: 10.1016/j.jep.2012.09.048] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
34 Chor SY, Hui AY, To KF, Chan KK, Go YY, Chan HL, Leung WK, Sung JJ. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. J Ethnopharmacol. 2005;100:180-186. [PMID: 15950418 DOI: 10.1016/j.jep.2005.02.036] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
35 Wang L, Wang X, Chen J, Yang Z, Yu L, Hu L, Shen X. Activation of protein serine/threonine phosphatase PP2Cα efficiently prevents liver fibrosis. PLoS One 2010;5:e14230. [PMID: 21151953 DOI: 10.1371/journal.pone.0014230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
36 Elpek GÖ. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol 2014;20:7260-76. [PMID: 24966597 DOI: 10.3748/wjg.v20.i23.7260] [Cited by in CrossRef: 161] [Cited by in F6Publishing: 137] [Article Influence: 26.8] [Reference Citation Analysis]
37 Ezhilarasan D, Evraerts J, Sid B, Calderon PB, Karthikeyan S, Sokal E, Najimi M. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression. Hepatobiliary & Pancreatic Diseases International 2017;16:80-7. [DOI: 10.1016/s1499-3872(16)60166-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
38 Dai L, Ji H, Kong XW, Zhang YH. Antifibrotic effects of ZK14, a novel nitric oxide-donating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCl4-induced hepatic fibrosis. Acta Pharmacol Sin 2010;31:27-34. [PMID: 19966836 DOI: 10.1038/aps.2009.170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
39 Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology. 2005;41:1085-1095. [PMID: 15841466 DOI: 10.1002/hep.20667] [Cited by in Crossref: 135] [Cited by in F6Publishing: 125] [Article Influence: 8.4] [Reference Citation Analysis]
40 Haldar D, Henderson NC, Hirschfield G, Newsome PN. Mesenchymal stromal cells and liver fibrosis: a complicated relationship. FASEB j 2016;30:3905-28. [DOI: 10.1096/fj.201600433r] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 9.2] [Reference Citation Analysis]
41 Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, Su M, Zhang M, Zhuge Y. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep 2016;6:34330. [PMID: 27680712 DOI: 10.1038/srep34330] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
42 Braz MM, Ramalho FS, Cardoso RL, Zucoloto S, Costa RS, Ramalho LN. Slight activation of nuclear factor kappa-B is associated with increased hepatic stellate cell apoptosis in human schistosomal fibrosis. Acta Tropica 2010;113:66-71. [DOI: 10.1016/j.actatropica.2009.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
43 Elrick LJ, Leel V, Blaylock MG, Duncan L, Drever MR, Strachan G, Charlton KA, Koruth M, Porter AJ, Wright MC. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics. J Hepatol. 2005;42:888-896. [PMID: 15885360 DOI: 10.1016/j.jhep.2005.01.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
44 Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008;12:939-62, xi. [PMID: 18984475 DOI: 10.1016/j.cld.2008.07.011] [Cited by in Crossref: 112] [Cited by in F6Publishing: 97] [Article Influence: 9.3] [Reference Citation Analysis]
45 Taimr P. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003;37:87-95. [DOI: 10.1053/jhep.2003.50002] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 8.6] [Reference Citation Analysis]
46 Xu T, Lu Z, Xiao Z, Liu F, Chen Y, Wang Z, Zhu S, Song Y. Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-ɑvβ6 integrin in liver fibrosis. Cell Death Dis 2020;11:199. [PMID: 32251270 DOI: 10.1038/s41419-020-2372-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Henderson NC, Iredale JP. Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond). 2007;112:265-280. [PMID: 17261089 DOI: 10.1042/cs20060242] [Cited by in Crossref: 183] [Cited by in F6Publishing: 80] [Article Influence: 13.1] [Reference Citation Analysis]
48 Teixeira R, Marcos LA, Friedman SL. Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. Hepatology Research 2007;37:579-95. [DOI: 10.1111/j.1872-034x.2007.00085.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
49 Henderson NC, Iredale JP. Standing down the guard: stellate cells leave quietly. Gastroenterology. 2012;143:890-892. [PMID: 22917861 DOI: 10.1053/j.gastro.2012.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
50 Chong LW, Hsu YC, Chiu YT, Yang KC, Huang YT. Antifibrotic effects of triptolide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats. Phytother Res 2011;25:990-9. [PMID: 21213358 DOI: 10.1002/ptr.3381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
51 Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat 2009;16:141-8. [PMID: 19175868 DOI: 10.1111/j.1365-2893.2008.01052.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
52 Chakraborty JB, Oakley F, Walsh MJ. Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. Int J Hepatol. 2012;2012:648915. [PMID: 22567408 DOI: 10.1155/2012/648915] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
53 Leitch AC, Abdelghany TM, Charlton A, Grigalyte J, Oakley F, Borthwick LA, Reed L, Knox A, Reilly WJ, Agius L, Blain PG, Wright MC. Renal injury and hepatic effects from the methylimidazolium ionic liquid M8OI in mouse. Ecotoxicol Environ Saf 2020;202:110902. [PMID: 32634706 DOI: 10.1016/j.ecoenv.2020.110902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
54 Stewart RK, Dangi A, Huang C, Murase N, Kimura S, Stolz DB, Wilson GC, Lentsch AB, Gandhi CR. A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. J Hepatol. 2014;60:298-305. [PMID: 24060854 DOI: 10.1016/j.jhep.2013.09.013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
55 Hui AY, Leung WK, Chan HL, Chan FK, Go MY, Chan KK, Tang BD, Chu ES, Sung JJ. Effect of celecoxib on experimental liver fibrosis in rat. Liver Int. 2006;26:125-136. [PMID: 16420518 DOI: 10.1111/j.1478-3231.2005.01202.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
56 Wang L, Yue Z, Guo M, Fang L, Bai L, Li X, Tao Y, Wang S, Liu Q, Zhi D, Zhao H. Dietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF-κB Signaling. Biomed Res Int 2016;2016:1068528. [PMID: 27110557 DOI: 10.1155/2016/1068528] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, Iredale JP. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology. 2009;49:901-910. [PMID: 19072833 DOI: 10.1002/hep.22701] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
58 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol. 2010;1:69-84. [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
59 Yang R, Deng H, Hou J, Li W, Zhang C, Yu M, Tang Y, Li Q, Li F, Song B, Zhang Z, Jiang C, Shen H. Investigation of salmon calcitonin in regulating fibrosis‐related molecule production and cell‐substrate adhesion in frozen shoulder synovial/capsular fibroblasts. J Orthop Res 2020;38:1375-85. [DOI: 10.1002/jor.24571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
60 Hagens WI, Beljaars L, Mann D, Wright MC, Julien B, Lotersztajn S, Reker-smit C, Poelstra K. Cellular Targeting of the Apoptosis-Inducing Compound Gliotoxin to Fibrotic Rat Livers. J Pharmacol Exp Ther 2008;324:902-10. [DOI: 10.1124/jpet.107.132290] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
61 Albanis E, Safadi R, Friedman SL. Treatment of hepatic fibrosis: almost there. Curr Gastroenterol Rep. 2003;5:48-56. [PMID: 12530948 DOI: 10.1007/s11894-003-0009-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
62 Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003;12:499-507. [PMID: 12953924 DOI: 10.3727/000000003108747064] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
63 Canbay A, Friedman S, Gores GJ. Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004;39:273-278. [PMID: 14767974 DOI: 10.1002/hep.20051] [Cited by in Crossref: 364] [Cited by in F6Publishing: 330] [Article Influence: 21.4] [Reference Citation Analysis]
64 Liu XJ, Yang L, Wu HB, Qiang O, Huang MH, Wang YP. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J Gastroenterol 2002;8:734-8. [PMID: 12174388 DOI: 10.3748/wjg.v8.i4.734] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
65 van Westerloo DJ, Florquin S, de Boer AM, Daalhuisen J, de Vos AF, Bruno MJ, van der Poll T. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol. 2005;166:721-728. [PMID: 15743784 DOI: 10.1016/s0002-9440(10)62293-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
66 Nejak-Bowen KN, Orr AV, Bowen WC Jr, Michalopoulos GK. Gliotoxin-induced changes in rat liver regeneration after partial hepatectomy. Liver Int 2013;33:1044-55. [PMID: 23552057 DOI: 10.1111/liv.12164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
67 Fallowfield JA, Iredale JP. Reversal of liver fibrosis and cirrhosis-an emerging reality. Scott Med J. 2004;49:3-6. [PMID: 15012043 DOI: 10.1177/003693300404900101] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
68 Roderfeld M, Geier A, Dietrich CG, Siewert E, Jansen B, Gartung C, Roeb E. Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury. Liver Int. 2006;26:579-586. [PMID: 16762003 DOI: 10.1111/j.1478-3231.2006.01271.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
69 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
70 Lin M, Chang Y, Xie F, Shi Y, Pang L, Chen D. ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy. Dig Dis Sci 2018;63:146-54. [PMID: 29196956 DOI: 10.1007/s10620-017-4816-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
71 Sharma S, Ghufran SM, Ghose S, Biswas S. Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells. Sci Rep 2021;11:3089. [PMID: 33542321 DOI: 10.1038/s41598-021-82381-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Li Z, Hu DY, Chu Q, Wu JH, Gao C, Zhang YQ, Huang YR. Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization. World J Gastroenterol. 2004;10:1876-1880. [PMID: 15222027 DOI: 10.3748/wjg.v10.i13.1876] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
73 Parajuli DR, Park EJ, Che XH, Jiang WY, Kim YC, Sohn DH, Lee SH. PF2401-SF, standardized fraction of Salvia miltiorrhiza, induces apoptosis of activated hepatic stellate cells in vitro and in vivo. Molecules 2013;18:2122-34. [PMID: 23389256 DOI: 10.3390/molecules18022122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
74 Marek CJ, Tucker SJ, Konstantinou DK, Elrick LJ, Haefner D, Sigalas C, Murray GI, Goodwin B, Wright MC. Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J 2005;387:601-8. [PMID: 15595924 DOI: 10.1042/BJ20041598] [Cited by in Crossref: 70] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
75 Davis GL, Krawczynski K, Szabo G. Hepatitis C Virus Infection—Pathobiology and Implications for New Therapeutic Options. Dig Dis Sci 2007;52:857-75. [DOI: 10.1007/s10620-006-9484-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Kumar V, Mundra V, Mahato RI. Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis. Pharm Res 2014;31:1158-69. [PMID: 24249038 DOI: 10.1007/s11095-013-1239-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
77 Hamid M, Liu D, Abdulrahim Y, Liu Y, Qian G, Khan A, Gan F, Huang K. Amelioration of CCl4-induced liver injury in rats by selenizing Astragalus polysaccharides: Role of proinflammatory cytokines, oxidative stress and hepatic stellate cells. Research in Veterinary Science 2017;114:202-11. [DOI: 10.1016/j.rvsc.2017.05.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
78 Orr JG, Leel V, Cameron GA, Marek CJ, Haughton EL, Elrick LJ, Trim JE, Hawksworth GM, Halestrap AP, Wright MC. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology. 2004;40:232-242. [PMID: 15239107 DOI: 10.1002/hep.20254] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
79 Cui D, Zhang S, Ma J, Han J, Jiang H. Short interfering RNA targetting NF-kappa B induces apoptosis of hepatic stellate cells and attenuates extracellular matrix production. Dig Liver Dis 2010;42:813-7. [PMID: 20409762 DOI: 10.1016/j.dld.2010.03.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
80 Ding H, Shi J, Wang Y, Guo J, Zhao J, Dong L. Neferine inhibits cultured hepatic stellate cell activation and facilitates apoptosis: A possible molecular mechanism. Eur J Pharmacol 2011;650:163-9. [PMID: 20969858 DOI: 10.1016/j.ejphar.2010.10.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
81 Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem. 2002;277:11069-11076. [PMID: 11796725 DOI: 10.1074/jbc.m111490200] [Cited by in Crossref: 310] [Cited by in F6Publishing: 132] [Article Influence: 16.3] [Reference Citation Analysis]
82 Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, Petrai I, Mazzocca A, Bonacchi A, De Franco RS, Colombatto S, Autelli R, Pinzani M, Parola M. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-82. [PMID: 16423888 DOI: 10.1136/gut.2005.082701] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 7.7] [Reference Citation Analysis]
83 Liu Y, Liu Q, Ye G, Khan A, Liu J, Gan F, Zhang X, Kumbhar S, Huang K. Protective effects of Selenium-enriched probiotics on carbon tetrachloride-induced liver fibrosis in rats. J Agric Food Chem 2015;63:242-9. [PMID: 25513970 DOI: 10.1021/jf5039184] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
84 Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, Saibara T, Shibasaki F, Kohara M, Kimura K. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice. EBioMedicine. 2015;2:1751-1758. [PMID: 26870800 DOI: 10.1016/j.ebiom.2015.10.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
85 Luna J, Masamunt MC, Lawrance IC, Sans M. Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol 2011;300:G703-8. [PMID: 21233275 DOI: 10.1152/ajpgi.00504.2010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
86 Douglass A, Wallace K, Koruth M, Barelle C, Porter AJ, Wright MC. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatol Int 2008;2:405-15. [PMID: 19669316 DOI: 10.1007/s12072-008-9093-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
87 Friedman SL. Hepatic fibrosis-overview. Toxicology. 2008;254:120-129. [PMID: 18662740 DOI: 10.1016/j.tox.2008.06.013] [Cited by in Crossref: 240] [Cited by in F6Publishing: 203] [Article Influence: 18.5] [Reference Citation Analysis]
88 Tashiro K, Satoh A, Utsumi T, Chung C, Iwakiri Y. Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice. Am J Pathol 2013;182:786-95. [PMID: 23313137 DOI: 10.1016/j.ajpath.2012.11.032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
89 Kim JW, Yang D, Jeong H, Park IS, Lee MH, Lim CW, Kim B. Dietary zerumbone, a sesquiterpene, ameliorates hepatotoxin-mediated acute and chronic liver injury in mice. Phytother Res 2019;33:1538-50. [PMID: 30868670 DOI: 10.1002/ptr.6346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Pan Q, Li DG, Lu HM, Lu LY, Wang YQ, Xu QF. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World J Gastroenterol 2004;10:1015-8. [PMID: 15052685 DOI: 10.3748/wjg.v10.i7.1015] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
91 Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010;138:705-714, 714.e1-714.e4. [PMID: 19843474 DOI: 10.1053/j.gastro.2009.10.002] [Cited by in Crossref: 264] [Cited by in F6Publishing: 257] [Article Influence: 22.0] [Reference Citation Analysis]
92 Kim JK, Han NR, Park SM, Jegal KH, Jung JY, Jung EH, Kim EO, Kim D, Jung DH, Lee JR, Park CA, Ku SK, Cho IJ, Kim SC. Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-κB and Akt. Food Chem Toxicol 2020;135:111044. [PMID: 31830547 DOI: 10.1016/j.fct.2019.111044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
93 Kitto LJ, Henderson NC. Hepatic Stellate Cell Regulation of Liver Regeneration and Repair. Hepatol Commun 2021;5:358-70. [PMID: 33681672 DOI: 10.1002/hep4.1628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kupfahl C, Ruppert T, Dietz A, Geginat G, Hof H. Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro. FEMS Yeast Research 2007;7:986-92. [DOI: 10.1111/j.1567-1364.2007.00256.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
95 Mühlbauer M, Weiss TS, Thasler WE, Gelbmann CM, Schnabl B, Schölmerich J, Hellerbrand C. LPS-mediated NFκB activation varies between activated human hepatic stellate cells from different donors. Biochemical and Biophysical Research Communications 2004;325:191-7. [DOI: 10.1016/j.bbrc.2004.10.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
96 Gupta G, Khadem F, Uzonna JE. Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity. Cytokine 2019;124:154542. [PMID: 30241896 DOI: 10.1016/j.cyto.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
97 Barnaeva E, Nadezhda A, Hannappel E, Sjogren MH, Rojkind M. Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells. Ann N Y Acad Sci 2007;1112:154-60. [PMID: 17584975 DOI: 10.1196/annals.1415.035] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
98 Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut. 2006;55:1073-1074. [PMID: 16849344 DOI: 10.1136/gut.2005.090449] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
99 Rockey DC. Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies. Clin Gastroenterol Hepatol. 2013;11:224-31.e1-5. [PMID: 23305825 DOI: 10.1016/j.cgh.2013.01.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
100 Lopez-Sanchez I, Dunkel Y, Roh YS, Mittal Y, De Minicis S, Muranyi A, Singh S, Shanmugam K, Aroonsakool N, Murray F, Ho SB, Seki E, Brenner DA, Ghosh P. GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. Nat Commun 2014;5:4451. [PMID: 25043713 DOI: 10.1038/ncomms5451] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 9.9] [Reference Citation Analysis]
101 Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: A summary of the Ron Thurman Symposium. Hepatology 2006;43:872-8. [DOI: 10.1002/hep.21107] [Cited by in Crossref: 115] [Cited by in F6Publishing: 101] [Article Influence: 7.7] [Reference Citation Analysis]
102 Kwak KA, Cho HJ, Yang JY, Park YS. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. Can J Gastroenterol Hepatol. 2018;2018:4197857. [PMID: 29670867 DOI: 10.1155/2018/4197857] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
103 Pinzani M. Unraveling the spider web of hepatic stellate cell apoptosis. Gastroenterology 2009;136:2061-3. [PMID: 19416764 DOI: 10.1053/j.gastro.2009.04.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
104 Zhang X, Han X, Yin L, Xu L, Qi Y, Xu Y, Sun H, Lin Y, Liu K, Peng J. Potent effects of dioscin against liver fibrosis. Sci Rep. 2015;5:9713. [PMID: 25853178 DOI: 10.1038/srep09713] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
105 Fischer R, Cariers A, Reinehr R, Häussinger D. Caspase 9-dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology. 2002;123:845-861. [PMID: 12198711 DOI: 10.1053/gast.2002.35384] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 3.6] [Reference Citation Analysis]
106 Uyama N, Shimahara Y, Okuyama H, Kawada N, Kamo S, Ikeda K, Yamaoka Y. Carbenoxolone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. Journal of Hepatology 2003;39:749-55. [DOI: 10.1016/s0168-8278(03)00375-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
107 Reinehr R, Sommerfeld A, Häussinger D. CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells. Gastroenterology 2008;134:1494-506. [PMID: 18471522 DOI: 10.1053/j.gastro.2008.02.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
108 Smith PG, Oakley F, Fernandez M, Mann DA, Lemoine NR, Whitehouse A. Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging. Gene Ther 2005;12:1465-76. [PMID: 15889136 DOI: 10.1038/sj.gt.3302543] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
109 Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, Lan HY, Sung JJ, Yu J. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget. 2015;6:7325-7338. [PMID: 25356754 DOI: 10.18632/oncotarget.2621] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 20.6] [Reference Citation Analysis]
110 Zhang Y, Ikegami T, Honda A, Miyazaki T, Bouscarel B, Rojkind M, Hyodo I, Matsuzaki Y. Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats. Hepatology. 2006;44:612-622. [PMID: 16941698 DOI: 10.1002/hep.21315] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
111 Török NJ. Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol. 2008;43:315-321. [PMID: 18592147 DOI: 10.1007/s00535-008-2181-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
112 Shimamura T, Fujisawa T, Husain SR, Kioi M, Nakajima A, Puri RK. Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J Immunol 2008;181:4656-65. [PMID: 18802068 DOI: 10.4049/jimmunol.181.7.4656] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
113 Campana L, Iredale JP. Extracellular Matrix Metabolism and Fibrotic Disease. Curr Pathobiol Rep 2014;2:217-24. [DOI: 10.1007/s40139-014-0058-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
114 Lee JI, Lee KS, Paik YH, Nyun Park Y, Han KH, Chon CY, Moon YM. Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J Hepatol. 2003;39:960-966. [PMID: 14642612 DOI: 10.1016/s0168-8278(03)00411-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
115 Xia JR, Liu NF, Zhu NX. Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats. Int J Mol Sci. 2008;9:638-661. [PMID: 19325776 DOI: 10.3390/ijms9040638] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
116 Mann DA, Smart DE. Transcriptional regulation of hepatic stellate cell activation. Gut 2002;50:891-6. [PMID: 12010897 DOI: 10.1136/gut.50.6.891] [Cited by in Crossref: 140] [Cited by in F6Publishing: 126] [Article Influence: 7.4] [Reference Citation Analysis]
117 Yu DM, Wang XM, McCaughan GW, Gorrell MD. Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J. 2006;273:2447-2460. [PMID: 16704418 DOI: 10.1111/j.1742-4658.2006.05253.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
118 Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010;53:132-144. [PMID: 20447716 DOI: 10.1016/j.jhep.2010.02.027] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 14.5] [Reference Citation Analysis]
119 Khurana A, Sayed N, Allawadhi P, Weiskirchen R. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis. Ann Transl Med 2021;9:728. [PMID: 33987426 DOI: 10.21037/atm-20-2948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
120 Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol. 2009;8:283-291. [PMID: 20009126 DOI: 10.1016/s1665-2681(19)31740-5] [Cited by in Crossref: 69] [Article Influence: 6.3] [Reference Citation Analysis]
121 Gardiner DM, Waring P, Howlett BJ. The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology 2005;151:1021-32. [DOI: 10.1099/mic.0.27847-0] [Cited by in Crossref: 309] [Cited by in F6Publishing: 222] [Article Influence: 19.3] [Reference Citation Analysis]
122 Peng L, Jia X, Zhao J, Cui R, Yan M. Substance P promotes hepatic stellate cell proliferation and activation via the TGF-β1/Smad-3 signaling pathway. Toxicology and Applied Pharmacology 2017;329:293-300. [DOI: 10.1016/j.taap.2017.06.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
123 Lakner AM, Walling TL, McKillop IH, Schrum LW. Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation. Liver Int 2011;31:42-51. [PMID: 20958918 DOI: 10.1111/j.1478-3231.2010.02356.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
124 Jiang JX, Mikami K, Venugopal S, Li Y, Török NJ. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways. J Hepatol 2009;51:139-48. [PMID: 19457567 DOI: 10.1016/j.jhep.2009.03.024] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 8.9] [Reference Citation Analysis]
125 Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH. Liver Myofibroblasts Regulate Infiltration and Positioning of Lymphocytes in Human Liver. Gastroenterology 2009;136:705-14. [DOI: 10.1053/j.gastro.2008.10.020] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 8.1] [Reference Citation Analysis]
126 Federico A, Trappoliere M, Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig Liver Dis. 2006;38:789-801. [PMID: 16750661 DOI: 10.1016/j.dld.2006.04.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
127 Upperman JS, Potoka DA, Zhang XR, Wong K, Zamora R, Ford HR. Mechanism of intestinal-derived fungal sepsis by gliotoxin, a fungal metabolite. J Pediatr Surg 2003;38:966-70. [PMID: 12778404 DOI: 10.1016/s0022-3468(03)00135-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
128 Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology. 2006;43:335-344. [PMID: 16440346 DOI: 10.1002/hep.21036] [Cited by in Crossref: 90] [Cited by in F6Publishing: 91] [Article Influence: 6.0] [Reference Citation Analysis]
129 Ikeda H, Yatomi Y. Autotaxin in liver fibrosis. Clin Chim Acta. 2012;413:1817-1821. [PMID: 22820036 DOI: 10.1016/j.cca.2012.07.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
130 Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 2003;327:143-147. [PMID: 12869458 DOI: 10.1136/bmj.327.7407.143] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 6.9] [Reference Citation Analysis]
131 Brunati AM, Pagano MA, Bindoli A, Rigobello MP. Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes. Free Radic Res 2010;44:363-78. [PMID: 20166884 DOI: 10.3109/10715760903555836] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
132 Iredale JP. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ. 2003;327:143-147. [PMID: 12869458 DOI: 10.1136/bmj.327.7407.143;327/7407/143] [Reference Citation Analysis]
133 Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, May MJ, Millward-Sadler H, Wright MC, Mann DA. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology. 2005;128:108-120. [PMID: 15633128 DOI: 10.1053/j.gastro.2004.10.003] [Cited by in Crossref: 197] [Cited by in F6Publishing: 190] [Article Influence: 12.3] [Reference Citation Analysis]
134 Atta HM. Reversibility and heritability of liver fibrosis: Implications for research and therapy. World J Gastroenterol 2015;21:5138-48. [PMID: 25954087 DOI: 10.3748/wjg.v21.i17.5138] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
135 Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis. 2008;12:915-937, xi. [PMID: 18984474 DOI: 10.1016/j.cld.2008.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
136 Hartland SN, Murphy F, Aucott RL, Abergel A, Zhou X, Waung J, Patel N, Bradshaw C, Collins J, Mann D, Benyon RC, Iredale JP. Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherin. Liver Int 2009;29:966-78. [PMID: 19580633 DOI: 10.1111/j.1478-3231.2009.02070.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
137 Amer AO, Probert PM, Dunn M, Knight M, Vallance AE, Flecknell PA, Oakley F, Cameron I, White SA, Blain PG, Wright MC. Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation. PLoS One 2015;10:e0136173. [PMID: 26302150 DOI: 10.1371/journal.pone.0136173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
138 Wang XM, Yu DM, McCaughan GW, Gorrell MD. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology. 2005;42:935-945. [PMID: 16175601 DOI: 10.1002/hep.20853] [Cited by in Crossref: 111] [Cited by in F6Publishing: 130] [Article Influence: 6.9] [Reference Citation Analysis]
139 Albanis E, Friedman SL. Antifibrotic agents for liver disease. Am J Transplant. 2006;6:12-19. [PMID: 16433751 DOI: 10.1111/j.1600-6143.2005.01143.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
140 Lee SH, Zhao YZ, Park EJ, Che XH, Seo GS, Sohn DH. 2',4',6'-Tris(methoxymethoxy) chalcone induces apoptosis by enhancing Fas-ligand in activated hepatic stellate cells. Eur J Pharmacol. 2011;658:9-15. [PMID: 21349266 DOI: 10.1016/j.ejphar.2011.01.067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
141 Oakley F, Teoh V, Ching-A-Sue G, Bataller R, Colmenero J, Jonsson JR, Eliopoulos AG, Watson MR, Manas D, Mann DA. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-2344.e1. [PMID: 19303015 DOI: 10.1053/j.gastro.2009.02.081] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
142 Hannivoort RA, Dunning S, Vander Borght S, Schroyen B, Woudenberg J, Oakley F, Buist-homan M, van den Heuvel FAJ, Geuken M, Geerts A, Roskams T, Faber KN, Moshage H. Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology 2008;48:624-34. [DOI: 10.1002/hep.22346] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
143 Anselmi K, Stolz DB, Nalesnik M, Watkins SC, Kamath R, Gandhi CR. Gliotoxin causes apoptosis and necrosis of rat Kupffer cells in vitro and in vivo in the absence of oxidative stress: exacerbation by caspase and serine protease inhibition. J Hepatol 2007;47:103-13. [PMID: 17466404 DOI: 10.1016/j.jhep.2007.02.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
144 Hubmann R, Sieghart W, Schnabl S, Araghi M, Hilgarth M, Reiter M, Demirtas D, Valent P, Zielinski C, Jäger U, Shehata M. Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model. Front Pharmacol 2017;8:319. [PMID: 28736522 DOI: 10.3389/fphar.2017.00319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
145 Robinson SM, Mann DA. Role of nuclear factor kappaB in liver health and disease. Clin Sci (Lond). 2010;118:691-705. [PMID: 20350292 DOI: 10.1042/CS20090549] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
146 Luli S, Di Paolo D, Perri P, Brignole C, Hill SJ, Brown H, Leslie J, Marshall HL, Wright MC, Mann DA, Ponzoni M, Oakley F. A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo. J Hepatol 2016;65:75-83. [PMID: 27067455 DOI: 10.1016/j.jhep.2016.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
147 Xie YH, Tang CQ, Huang ZZ, Zhou SC, Yang YW, Yin Z, Heng BC, Chen WS, Chen X, Shen WL. ECM remodeling in stem cell culture: a potential target for regulating stem cell function. Tissue Eng Part B Rev 2021. [PMID: 34082581 DOI: 10.1089/ten.TEB.2021.0066] [Reference Citation Analysis]
148 Stefano JT, Cogliati B, Santos F, Lima VM, Mazo DC, Matte U, Alvares-da-Silva MR, Silveira TR, Carrilho FJ, Oliveira CP. S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro. Nitric Oxide 2011;25:360-5. [PMID: 21820071 DOI: 10.1016/j.niox.2011.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
149 Ye Z, Houssein HS, Mahato RI. Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides 2007;17:349-404. [PMID: 18154454 DOI: 10.1089/oli.2007.0097] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
150 Hudec R, Lakatos B, Kaiserová K, Orlický J, Varecka L. Properties of the basal calcium influx in human red blood cells. Biochim Biophys Acta 2004;1661:204-11. [PMID: 15003883 DOI: 10.1016/j.bbamem.2004.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
151 Czech B, Dettmer K, Valletta D, Saugspier M, Koch A, Stevens AP, Thasler WE, Müller M, Oefner PJ, Bosserhoff AK, Hellerbrand C. Expression and function of methylthioadenosine phosphorylase in chronic liver disease. PLoS One 2013;8:e80703. [PMID: 24324622 DOI: 10.1371/journal.pone.0080703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
152 Siegmund SV, Qian T, de Minicis S, Harvey-White J, Kunos G, Vinod KY, Hungund B, Schwabe RF. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 2007;21:2798-2806. [PMID: 17440119 DOI: 10.1096/fj.06-7717com] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 6.9] [Reference Citation Analysis]
153 Siegmund SV, Brenner DA. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res. 2005;29:102S-109S. [PMID: 16344593 DOI: 10.1097/01.alc.0000189275.97419.58] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
154 Liu H, Wang Z, Nowicki MJ. Caspase-12 mediates carbon tetrachloride-induced hepatocyte apoptosis in mice. World J Gastroenterol 2014;20:18189-98. [PMID: 25561786 DOI: 10.3748/wjg.v20.i48.18189] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
155 Li H, Zhang L, Cai N, Zhang B, Sun S. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3. Ann Hepatol 2021;23:100305. [PMID: 33434689 DOI: 10.1016/j.aohep.2021.100305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Benten D, Kumaran V, Joseph B, Schattenberg J, Popov Y, Schuppan D, Gupta S. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology. 2005;42:1072-1081. [PMID: 16250034 DOI: 10.1002/hep.20889] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
157 Türkay C, Yönem O, Arici S, Koyuncu A, Kanbay M. Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci. 2008;53:789-793. [PMID: 17763951 DOI: 10.1007/s10620-007-9941-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
158 Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Journal of Ethnopharmacology 2018;210:232-41. [DOI: 10.1016/j.jep.2017.08.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
159 Luk JM, Zhang Q, Lee NP, Wo JY, Leung PP, Liu L, Hu M, Cheung K, Hui C, Lau GK, Fan S. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Liver Int 2007;27:548-57. [DOI: 10.1111/j.1478-3231.2007.01452.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
160 Zhou YJ, Yin DM, Chen HS, Shi JH, Sha BX, Wang X. Inhibitory effects of idoxifene on hepatic fibrosis in rats. Acta Pharmacol Sin. 2005;26:581-586. [PMID: 15842777 DOI: 10.1111/j.1745-7254.2005.00082.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
161 Axon A, Cowie DE, Mann DA, Wright MC. A mechanism for the anti-fibrogenic effects of the pregnane X receptor (PXR) in the liver: inhibition of NF-kappaB? Toxicology 2008;246:40-4. [PMID: 18194834 DOI: 10.1016/j.tox.2007.12.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
162 Lin YL, Lin CY, Chi CW, Huang YT. Study on antifibrotic effects of curcumin in rat hepatic stellate cells. Phytother Res. 2009;23:927-932. [PMID: 19152370 DOI: 10.1002/ptr.2764] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
163 Fowell AJ, Iredale JP. Emerging therapies for liver fibrosis. Dig Dis. 2006;24:174-183. [PMID: 16699275 DOI: 10.1159/000090320] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
164 Cordero-Espinoza L, Huch M. The balancing act of the liver: tissue regeneration versus fibrosis. J Clin Invest 2018;128:85-96. [PMID: 29293095 DOI: 10.1172/JCI93562] [Cited by in Crossref: 77] [Cited by in F6Publishing: 44] [Article Influence: 25.7] [Reference Citation Analysis]
165 Zhang XL, Liu L, Jiang HQ. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation. World J Gastroenterol 2002;8:515-9. [PMID: 12046082 DOI: 10.3748/wjg.v8.i3.515] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
166 Planagumà A, Clària J, Miquel R, López-Parra M, Titos E, Masferrer JL, Arroyo V, Rodés J. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J. 2005;19:1120-1122. [PMID: 15876570 DOI: 10.1096/fj.04-2753fje] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 6.1] [Reference Citation Analysis]
167 Marrone G, Maeso-Díaz R, García-Cardena G, Abraldes JG, García-Pagán JC, Bosch J, Gracia-Sancho J. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Gut. 2015;64:1434-1443. [PMID: 25500203 DOI: 10.1136/gutjnl-2014-308338] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 13.7] [Reference Citation Analysis]
168 Jordan TW. The cellular and molecular toxicity of sporidesmin. N Z Vet J 2020;68:203-13. [PMID: 32054403 DOI: 10.1080/00480169.2020.1729268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Lemoinne S, Cadoret A, El Mourabit H, Thabut D, Housset C. Origins and functions of liver myofibroblasts. Biochim Biophys Acta. 2013;1832:948-954. [PMID: 23470555 DOI: 10.1016/j.bbadis.2013.02.019] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 10.4] [Reference Citation Analysis]
170 Zhao WX, Zhao J, Liang CL, Zhao B, Pang RQ, Pan XH. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitro. World J Gastroenterol 2003;9:1278-81. [PMID: 12800240 DOI: 10.3748/wjg.v9.i6.1278] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
171 Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R. Gliotoxin ameliorates development of fibrosis and cirrhosis ina thioacetamide rat model. Dig Dis Sci. 2003;48:1642-1647. [PMID: 12924662 DOI: 10.1023/A:1024792529601] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
172 Nguyen VT, Lee JS, Qian ZJ, Li YX, Kim KN, Heo SJ, Jeon YJ, Park WS, Choi IW, Je JY, Jung WK. Gliotoxin isolated from marine fungus Aspergillus sp. induces apoptosis of human cervical cancer and chondrosarcoma cells. Mar Drugs 2013;12:69-87. [PMID: 24368570 DOI: 10.3390/md12010069] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
173 Ghazwani M, Zhang Y, Gao X, Fan J, Li J, Li S. Anti-fibrotic effect of thymoquinone on hepatic stellate cells. Phytomedicine. 2014;21:254-260. [PMID: 24182989 DOI: 10.1016/j.phymed.2013.09.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
174 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
175 de Mesquita FC, Guixé-Muntet S, Fernández-Iglesias A, Maeso-Díaz R, Vila S, Hide D, Ortega-Ribera M, Rosa JL, García-Pagán JC, Bosch J, de Oliveira JR, Gracia-Sancho J. Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies. Sci Rep 2017;7:3255. [PMID: 28607430 DOI: 10.1038/s41598-017-02866-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
176 Zhou Z, Qi J, Zhao J, Lim CW, Kim JW, Kim B. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice. J Cell Mol Med 2020;24:1383-98. [PMID: 31821710 DOI: 10.1111/jcmm.14817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
177 Jiao J, Friedman SL, Aloman C. Hepatic fibrosis. Curr Opin Gastroenterol. 2009;25:223-229. [PMID: 19396960 DOI: 10.1097/MOG.0b013e3283279668] [Cited by in Crossref: 149] [Cited by in F6Publishing: 71] [Article Influence: 12.4] [Reference Citation Analysis]
178 Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. J Gastroenterol Hepatol. 2007;22:99-111. [PMID: 17201889 DOI: 10.1111/j.1440-1746.2006.04361.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
179 Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol. 2006;21 Suppl 3:S84-S87. [PMID: 16958681 DOI: 10.1111/j.1440-1746.2006.04584.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 159] [Article Influence: 12.3] [Reference Citation Analysis]
180 Zhu H, He C, Zhao H, Jiang W, Xu S, Li J, Ma T, Huang C. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation. FASEB J 2020;34:14558-71. [PMID: 32946656 DOI: 10.1096/fj.202000494RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
181 Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G880-G886. [PMID: 12829436 DOI: 10.1152/ajpgi.00039.2003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
182 Wallace K, Cowie DE, Konstantinou DK, Hill SJ, Tjelle TE, Axon A, Koruth M, White SA, Carlsen H, Mann DA, Wright MC. The PXR is a drug target for chronic inflammatory liver disease. J Steroid Biochem Mol Biol 2010;120:137-48. [PMID: 20416375 DOI: 10.1016/j.jsbmb.2010.04.012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
183 Tasci I, Mas MR, Vural SA, Comert B, Alcigir G, Serdar M, Mas N, Isik AT, Ates Y. Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery. Liver Int. 2006;26:261-268. [PMID: 16448466 DOI: 10.1111/j.1478-3231.2005.01210.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
184 Dodig M, Mullen KD. New mechanism of selective killing of activated hepatic stellate cells. Hepatology. 2003;38:1051-1053. [PMID: 14567385 DOI: 10.1002/hep.1840380432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
185 Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199-210. [PMID: 18161745 DOI: 10.1002/path.2277] [Cited by in Crossref: 2468] [Cited by in F6Publishing: 2136] [Article Influence: 189.8] [Reference Citation Analysis]
186 Wallace K, Long Q, Fairhall EA, Charlton KA, Wright MC. Serine/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes. J Cell Sci 2011;124:405-13. [PMID: 21224398 DOI: 10.1242/jcs.077503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
187 Schoemaker MH, Rots MG, Beljaars L, Ypma AY, Jansen PL, Poelstra K, Moshage H, Haisma HJ. PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells. Mol Pharm. 2008;5:399-406. [PMID: 18217712 DOI: 10.1021/mp700118p] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
188 Lin Y, Lee T, Huang Y, Huang Y. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells. J Gastroenterol Hepatol 2006;21:1257-65. [DOI: 10.1111/j.1440-1746.2006.04326.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
189 Berardis S, Dwisthi Sattwika P, Najimi M, Sokal EM. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. World J Gastroenterol. 2015;21:742-758. [PMID: 25624709 DOI: 10.3748/wjg.v21.i3.742] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
190 Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005;3:95-107. [PMID: 15704042 DOI: 10.1016/s1542-3565(04)00445-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
191 Rickmann M, Vaquero EC, Malagelada JR, Molero X. Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology. 2007;132:2518-2532. [PMID: 17570223 DOI: 10.1053/j.gastro.2007.03.107] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
192 Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G, Hillan K, Kendall T, Benyon RC, Mann DA, Iredale JP. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol. 2003;163:1849-1858. [PMID: 14578185 DOI: 10.1016/s0002-9440(10)63544-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
193 De Minicis S, Candelaresi C, Agostinelli L, Taffetani S, Saccomanno S, Rychlicki C, Trozzi L, Marzioni M, Benedetti A, Svegliati-Baroni G. Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution. Liver Int. 2012;32:1574-1584. [PMID: 22938186 DOI: 10.1111/j.1478-3231.2012.02860.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
194 Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Watanabe N, Kitamura K, Isono T, Yahagi N, Noiri E, Inao M, Mochida S, Kume Y, Yatomi Y, Nakahara K, Omata M, Fujiwara K. The herbal medicine inchin-ko-to (TJ-135) induces apoptosis in cultured rat hepatic stellate cells. Life Sciences 2006;78:2226-33. [DOI: 10.1016/j.lfs.2005.09.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
195 Wu Z, Huang S, Zheng X, Gu S, Xu Q, Gong Y, Zhang J, Fu B, Tang L. Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review). Exp Ther Med 2021;21:351. [PMID: 33732324 DOI: 10.3892/etm.2021.9782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Ullah A, Wang K, Wu P, Oupicky D, Sun M. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation. Int J Nanomedicine 2019;14:2927-44. [PMID: 31118614 DOI: 10.2147/IJN.S171280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
197 Pinchuk IV, Mifflin RC, Saada JI, Powell DW. Intestinal mesenchymal cells. Curr Gastroenterol Rep 2010;12:310-8. [PMID: 20690004 DOI: 10.1007/s11894-010-0135-y] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
198 Oakley F, Mann J, Ruddell RG, Pickford J, Weinmaster G, Mann DA. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J Biol Chem 2003;278:24359-70. [PMID: 12700242 DOI: 10.1074/jbc.M211051200] [Cited by in Crossref: 73] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
199 Wang X, Ikejima K, Kon K, Arai K, Aoyama T, Okumura K, Abe W, Sato N, Watanabe S. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol. 2011;55:379-387. [PMID: 21168456 DOI: 10.1016/j.jhep.2010.10.040] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
200 Fallowfield JA, Iredale JP. Targeted treatments for cirrhosis. Expert Opin Ther Targets. 2004;8:423-435. [PMID: 15469393 DOI: 10.1517/14728222.8.5.423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
201 Lv P, Luo HS, Zhou XP, Xiao YJ, Paul SC, Si XM, Zhou YH. Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappaB/inhibitor of nuclear factor-kappaB pathway. Arch Med Res. 2007;38:15-27. [PMID: 17174718 DOI: 10.1016/j.arcmed.2006.09.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
202 Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol. 2003;38 Suppl 1:S38-S53. [PMID: 12591185 DOI: 10.1016/s0168-8278(02)00429-4] [Cited by in Crossref: 1077] [Cited by in F6Publishing: 427] [Article Influence: 59.8] [Reference Citation Analysis]
203 Lin YL, Lee TF, Huang YJ, Huang YT. Antiproliferative effect of salvianolic acid A on rat hepatic stellate cells. J Pharm Pharmacol. 2006;58:933-939. [PMID: 16805953 DOI: 10.1211/jpp.58.7.0008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
204 Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, Iredale JP. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. 2007;178:5288-5295. [PMID: 17404313 DOI: 10.4049/jimmunol.178.8.5288] [Cited by in Crossref: 296] [Cited by in F6Publishing: 278] [Article Influence: 21.1] [Reference Citation Analysis]
205 Shen XH, Cheng WF, Li XH, Sun JQ, Li F, Ma L, Xie LM. Effects of dietary supplementation with vitamin E and selenium on rat hepatic stellate cell apoptosis. World J Gastroenterol 2005;11:4957-61. [PMID: 16124045 DOI: 10.3748/wjg.v11.i32.4957] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
206 Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol. 2016;22:6841-6850. [PMID: 27570421 DOI: 10.3748/wjg.v22.i30.6841] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 56] [Article Influence: 15.0] [Reference Citation Analysis]
207 Kurikawa N, Suga M, Kuroda S, Yamada K, Ishikawa H. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol. 2003;139:1085-1094. [PMID: 12871826 DOI: 10.1038/sj.bjp.0705339] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 5.4] [Reference Citation Analysis]
208 Wallace K, Marek CJ, Currie RA, Wright MC. Exocrine pancreas trans-differentiation to hepatocytes--a physiological response to elevated glucocorticoid in vivo. J Steroid Biochem Mol Biol. 2009;116:76-85. [PMID: 19446026 DOI: 10.1016/j.jsbmb.2009.05.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
209 Lee PJ, Park HJ, Cho N, Kim HP. 3,5-Diethoxy-3'-Hydroxyresveratrol (DEHR) Ameliorates Liver Fibrosis via Caveolin-1 Activation in Hepatic Stellate Cells and in a Mouse Model of Bile Duct Ligation Injury. Molecules 2018;23:E2833. [PMID: 30384491 DOI: 10.3390/molecules23112833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
210 Oakley F, Mann J, Nailard S, Smart DE, Mungalsingh N, Constandinou C, Ali S, Wilson SJ, Millward-Sadler H, Iredale JP, Mann DA. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol 2005;166:695-708. [PMID: 15743782 DOI: 10.1016/s0002-9440(10)62291-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
211 Natarajan SK, Thomas S, Ramamoorthy P, Basivireddy J, Pulimood AB, Ramachandran A, Balasubramanian KA. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol. 2006;21:947-957. [PMID: 16724977 DOI: 10.1111/j.1440-1746.2006.04231.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
212 Nieto N. A systems biology approach for understanding the collagen regulatory network in alcoholic liver disease. Liver Int 2012;32:189-98. [PMID: 21745314 DOI: 10.1111/j.1478-3231.2011.02573.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
213 Zhang P, Gan Z, Tang L, Zhou L, Huang X, Wang J. Exosomes from microRNA-145-5p-modified HUCB-MSCs attenuate CCl4-induced hepatic fibrosis via down-regulating FSCN1 expression. Life Sci 2021;:119404. [PMID: 33794251 DOI: 10.1016/j.lfs.2021.119404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1642] [Article Influence: 135.2] [Reference Citation Analysis]
215 Fang S, Yuan J, Shi Q, Xu T, Fu Y, Wu Z, Guo W. Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway. PLoS One 2017;12:e0174374. [PMID: 28358817 DOI: 10.1371/journal.pone.0174374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
216 Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181-194. [PMID: 24566915 DOI: 10.1038/nri3623] [Cited by in Crossref: 652] [Cited by in F6Publishing: 583] [Article Influence: 93.1] [Reference Citation Analysis]
217 Qian J, Zhang JS, Wang XQ, Ji JL, Mei S. Fenretinide stimulates the apoptosis of hepatic stellate cells and ameliorates hepatic fibrosis in mice. Hepatol Res. 2009;39:1229-1247. [PMID: 19788699 DOI: 10.1111/j.1872-034X.2009.00562.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
218 Watson MR, Wallace K, Gieling RG, Manas DM, Jaffray E, Hay RT, Mann DA, Oakley F. NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol. 2008;48:589-597. [PMID: 18279996 DOI: 10.1016/j.jhep.2007.12.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
219 Probert PM, Leitch AC, Dunn MP, Meyer SK, Palmer JM, Abdelghany TM, Lakey AF, Cooke MP, Talbot H, Wills C, McFarlane W, Blake LI, Rosenmai AK, Oskarsson A, Figueiredo R, Wilson C, Kass GE, Jones DE, Blain PG, Wright MC. Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis. J Hepatol 2018;69:1123-35. [PMID: 30006067 DOI: 10.1016/j.jhep.2018.06.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
220 Cheng W, Xiao L, Ainiwaer A, Wang Y, Wu G, Mao R, Yang Y, Bao Y. Molecular responses of radiation-induced liver damage in rats. Mol Med Rep 2015;11:2592-600. [PMID: 25483171 DOI: 10.3892/mmr.2014.3051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
221 Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2013;1832:876-883. [PMID: 23149387 DOI: 10.1016/j.bbadis.2012.11.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 126] [Article Influence: 16.2] [Reference Citation Analysis]
222 Siegmund SV, Dooley S, Brenner DA. Molecular Mechanisms of Alcohol-Induced Hepatic Fibrosis. Dig Dis 2006;23:264-74. [DOI: 10.1159/000090174] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
223 Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A, Wright MC, White SA, Jaffré F, Maroteaux L, Mann DA. Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med 2011;17:1668-73. [PMID: 22120177 DOI: 10.1038/nm.2490] [Cited by in Crossref: 136] [Cited by in F6Publishing: 105] [Article Influence: 13.6] [Reference Citation Analysis]
224 Zhang F, Kong DS, Zhang ZL, Lei N, Zhu XJ, Zhang XP, Chen L, Lu Y, Zheng SZ. Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro. Apoptosis. 2013;18:135-149. [PMID: 23247439 DOI: 10.1007/s10495-012-0791-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
225 Lonardo A, Loria P. Of liver, whisky and plants: a requiem for colchicine in alcoholic cirrhosis? Eur J Gastroenterol Hepatol 2002;14:355-8. [PMID: 11943945 DOI: 10.1097/00042737-200204000-00003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
226 Yu DM, Yao TW, Chowdhury S, Nadvi NA, Osborne B, Church WB, McCaughan GW, Gorrell MD. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J 2010;277:1126-44. [PMID: 20074209 DOI: 10.1111/j.1742-4658.2009.07526.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
227 Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 2005;105:2258-65. [PMID: 15546954 DOI: 10.1182/blood-2004-09-3421] [Cited by in Crossref: 135] [Cited by in F6Publishing: 102] [Article Influence: 7.9] [Reference Citation Analysis]
228 Yang Q, Liu HY, Zhang YW, Wu WJ, Tang WX. Anandamide induces cell death through lipid rafts in hepatic stellate cells. J Gastroenterol Hepatol. 2010;25:991-1001. [PMID: 20059638 DOI: 10.1111/j.1440-1746.2009.06122.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
229 Adrian JE, Poelstra K, Kamps JA. Addressing liver fibrosis with liposomes targeted to hepatic stellate cells. J Liposome Res. 2007;17:205-218. [PMID: 18027241 DOI: 10.1080/08982100701528047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
230 Yoon JH, Gores GJ. Death receptor-mediated apoptosis and the liver. J Hepatol. 2002;37:400-410. [PMID: 12175638 DOI: 10.1016/s0168-8278(02)00209-x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
231 Lee PJ, Woo SJ, Jee JG, Sung SH, Kim HP. Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. Molecules. 2015;20:1277-1292. [PMID: 25594342 DOI: 10.3390/molecules20011277] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
232 Lee M, Park JH, Min DS, Yoo H, Park JH, Kim YC, Sung SH. Antifibrotic Activity of Diarylheptanoids from Betula platyphylla toward HSC-T6 Cells. Bioscience, Biotechnology, and Biochemistry 2014;76:1616-20. [DOI: 10.1271/bbb.110887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
233 Haughton EL, Tucker SJ, Marek CJ, Durward E, Leel V, Bascal Z, Monaghan T, Koruth M, Collie-Duguid E, Mann DA, Trim JE, Wright MC. Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. Gastroenterology 2006;131:194-209. [PMID: 16831602 DOI: 10.1053/j.gastro.2006.04.012] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]
234 Konishi T, Schuster RM, Lentsch AB. Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis. Am J Physiol Gastrointest Liver Physiol 2019;316:G323-31. [PMID: 30543462 DOI: 10.1152/ajpgi.00154.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
235 Vilaseca M, Guixé-Muntet S, Fernández-Iglesias A, Gracia-Sancho J. Advances in therapeutic options for portal hypertension. Therap Adv Gastroenterol 2018;11:1756284818811294. [PMID: 30505350 DOI: 10.1177/1756284818811294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
236 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol. 2007;41:616-623. [PMID: 17577119 DOI: 10.1097/01.mcg.0000225642.90898.0e] [Cited by in Crossref: 135] [Cited by in F6Publishing: 122] [Article Influence: 9.6] [Reference Citation Analysis]
237 Elsharkawy AM, Mann DA. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology. 2007;46:590-597. [PMID: 17661407 DOI: 10.1002/hep.21802] [Cited by in Crossref: 275] [Cited by in F6Publishing: 244] [Article Influence: 19.6] [Reference Citation Analysis]
238 Schoemaker MH, Moshage H. Defying death: the hepatocyte's survival kit. Clinical Science 2004;107:13-25. [DOI: 10.1042/cs20040090] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
239 Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Gliotoxin-mediated apoptosis of activated humanhepatic stellate cells. J Hepatol. 2003;39:38-46. [PMID: 12821042 DOI: 10.1016/S0168-8278(03)00178-8] [Cited by in Crossref: 97] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
240 Bhatnagar I, Kim S. Gliotoxin from Aspergillus fumigatus reverses epithelial to mesenchymal transition: Implications in renal fibrosis. International Journal of Medical Microbiology 2015;305:11-9. [DOI: 10.1016/j.ijmm.2014.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
241 Hagens WI, Olinga P, Meijer DKF, Groothuis GMM, Beljaars L, Poelstra K. Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int 2006;26:232-9. [DOI: 10.1111/j.1478-3231.2005.01212.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
242 Wright MC. The impact of pregnane X receptor activation on liver fibrosis. Biochem Soc Trans 2006;34:1119-23. [PMID: 17073765 DOI: 10.1042/BST0341119] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
243 Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary & Pancreatic Diseases International 2018;17:192-7. [DOI: 10.1016/j.hbpd.2018.04.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 14.3] [Reference Citation Analysis]
244 Zeybel M, Luli S, Sabater L, Hardy T, Oakley F, Leslie J, Page A, Moran Salvador E, Sharkey V, Tsukamoto H, Chu DCK, Singh US, Ponzoni M, Perri P, Di Paolo D, Mendivil EJ, Mann J, Mann DA. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A. Mol Ther 2017;25:218-31. [PMID: 28129116 DOI: 10.1016/j.ymthe.2016.10.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
245 Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, Tang W. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 2019;18:130. [PMID: 31464625 DOI: 10.1186/s12943-019-1047-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 30.0] [Reference Citation Analysis]
246 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J. 2008;411:1-18. [PMID: 18333835 DOI: 10.1042/bj20071570] [Cited by in Crossref: 217] [Cited by in F6Publishing: 102] [Article Influence: 16.7] [Reference Citation Analysis]
247 Kubo N, Saito R, Hamano K, Nagasawa M, Aoki F, Takei I, Umezawa K, Kuwano H, Kojima I. Conophylline suppresses hepatic stellate cells and attenuates thioacetamide-induced liver fibrosis in rats. Liver Int. 2014;34:1057-1067. [PMID: 24119135 DOI: 10.1111/liv.12328] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
248 Yu G, Mu H, Zhou H, Fang F, Cui Y, Wu Q, Xiong Q, Li H. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65. Cells Dev 2021;167:203711. [PMID: 34216805 DOI: 10.1016/j.cdev.2021.203711] [Reference Citation Analysis]
249 Nakamuta M, Kotoh K, Enjoji M, Nawata H. Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE. World J Gastroenterol. 2005;11:2264-2268. [PMID: 15818737 DOI: 10.3748/wjg.v11.i15.2264] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
250 Campana L, Esser H, Huch M, Forbes S. Liver regeneration and inflammation: from fundamental science to clinical applications. Nat Rev Mol Cell Biol 2021;22:608-24. [PMID: 34079104 DOI: 10.1038/s41580-021-00373-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Chen G, Wang Y, Li M, Xu T, Wang X, Hong B, Niu Y. Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways. Eur J Pharm Sci 2014;65:21-8. [PMID: 25220584 DOI: 10.1016/j.ejps.2014.09.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
252 Panebianco C, Oben JA, Vinciguerra M, Pazienza V. Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings. Clin Exp Med. 2017;17:269-280. [PMID: 27655446 DOI: 10.1007/s10238-016-0438-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 8.6] [Reference Citation Analysis]
253 Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, Evans SM, Dillmann W, Glass CK, Brenner DA. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA. 2012;109:9448-9453. [PMID: 22566629 DOI: 10.1073/pnas.1201840109] [Cited by in Crossref: 453] [Cited by in F6Publishing: 419] [Article Influence: 50.3] [Reference Citation Analysis]